In addition, there are many diseases accompanied by fibrosis in clinical practice, such as cirrhosis, chronic obstructive pulmonary disease, and skin scars; if Fibulin-5 is used as a target in the future to find a new treatment, it may obtain a good therapeutic effect. This evidence concerns the gene FBLN5 and Cirrhosis.